Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Effect of the second-generation vascular disrupting agent OXi4503 on tumor vascularityHoward W Salmon, Dietmar W SiemannRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 14, 2004
Utility of 19F MRS detection of the hypoxic cell marker EF5 to assess cellular hypoxia in solid tumorsHoward W Salmon, Dietmar W SiemannEuropean Journal of Cancer (Oxford, England : 1990)|September 8, 2006
Evaluations of vascular disrupting agents CA4P and OXi4503 in renal cell carcinoma (Caki-1) using a silicon based microvascular casting techniqueHoward W Salmon, Christopher Mladinich, Dietmar W SiemannJournal of Medical Physics|January 4, 2018
The Impact of Dose Rate on the Accuracy of Step-and-Shoot Intensity-modulated Radiation Therapy Quality Assurance Using Varian 2300CDChristopher F Njeh, Howard W Salmon, Claire SchillerEuropean Journal of Cancer (Oxford, England : 1990)|April 25, 2007
Monitoring the treatment efficacy of the vascular disrupting agent CA4PBeth A Salmon, Howard W Salmon, Dietmar W SiemannAmerican Journal of Cancer Research|September 8, 2012
Vascular development in mouse lung metastasesHoward W Salmon, Ananya Guha, Amyn M Rojiani, et al.Pageof 1